Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
11/2013
11/27/2013EP2665481A2 Methods and compositions for treating metabolic syndrome
11/27/2013EP2665477A1 Modified release compositions of epalrestat or a derivative thereof and methods for using the same
11/27/2013CN103415506A Sec-hydroxycyclohexyl derivatives as hsl inhibitors for the treatment diabetes
11/27/2013CN103409323A Gynostemma endophytic fungi and application thereof
11/27/2013CN103409267A Health-care wine
11/27/2013CN103408710A Biodegradable and sugar responsive Y type polymer drug delivery material and preparation
11/27/2013CN103408676A Nadroparin calcium preparation technology
11/27/2013CN103408669A Fusion protein of GLP-1 analogue and preparation method and application thereof
11/27/2013CN103408573A Boric acid derivatives, and preparation method and application thereof
11/27/2013CN103408572A Chiral amino boric acid derivatives, and preparation method and application thereof
11/27/2013CN103408400A Inositol crystal as well as preparation method and use thereof
11/27/2013CN103408122A High-oxygen rich-hydrogen water and preparation method and application thereof
11/27/2013CN103405768A Methods for the treatment of IL-1[beta] related diseases
11/27/2013CN103405757A Composition for health-care product, health-care product and using method thereof
11/27/2013CN103405753A Stable exendin water injection medicine composition
11/27/2013CN103405748A Brand-new two-layer polymer covered polypeptide controlled-release composition
11/27/2013CN103405675A Drug for treating diabetes mellitus and preparation method thereof
11/27/2013CN103405661A Formula for treatment of diseases about fracture, bone fracture, calcium supplement and osteoporosis and preparation method
11/27/2013CN103405658A Drug for treating diabetes mellitus and preparation method thereof
11/27/2013CN103405655A Traditional Chinese medicine composition for reducing blood glucose and preparation method thereof
11/27/2013CN103405654A Traditional Chinese medicine pharmaceutical composition for treating diabetes and preparation method thereof
11/27/2013CN103405639A Phellinus igniarius polyose and traditional Chinese medicine compound blood-glucose lowering oral liquid and preparation method thereof
11/27/2013CN103405607A Traditional Chinese medicine for preventing and treating high blood pressure, high blood sugar and high blood fat
11/27/2013CN103405538A Chinese medicine compound formula capable of remarkably improving concentration of serum high density lipoprotein, and preparation method of Chinese medicine compound formula
11/27/2013CN103405537A Health protection product capable of reducing blood fat and improving immunity
11/27/2013CN103405514A Antihypertensive pillow with medicine inside
11/27/2013CN103405498A Compound lipid-lowering pills
11/27/2013CN103405493A Application of black bean and extractive of same in manufacture of preparation for inhibiting expression of hepcidin
11/27/2013CN103405473A Mixed carbohydrate-electrolyte injection and preparation method thereof
11/27/2013CN103405467A Application of theanine, tea polysaccharide and Rubus Suavissmus S, Lee extract as aldose reductase inhibitor
11/27/2013CN103405397A Capsule located in bioadhesive drug delivery manner for releasing beta glucosan
11/27/2013CN103405369A Tooth-protecting toothpaste
11/27/2013CN103404855A Grifola frondosa health care oral solution and preparation method thereof
11/27/2013CN103404638A Sugar-reducing tea leaves
11/27/2013CN103083270B Xanthophyll chewable tablet
11/27/2013CN102936547B Healthcare port wine
11/27/2013CN102936544B Healthcare beer
11/27/2013CN102895314B Medicine with weight-reducing and lipid-lowering functions
11/27/2013CN102757370B Derivatives of p-aminobenzoic acid and applications thereof
11/27/2013CN102743455B Chinese patent medicine for treating diabetes mellitus
11/27/2013CN102696804B Weight-loosing and bodybuilding traditional Chinese medicine tea
11/27/2013CN102688434B Traditional Chinese medicine (TCM) for treating diabetes
11/27/2013CN102670975B Selenium-enriched chromium-enriched medicine for adjuvant therapy of diabetes mellitus
11/27/2013CN102670935B Method for extracting total saponins from allium chinense
11/27/2013CN102579511B Method for integrally extracting steroidal compounds, polysaccharides and polyphenols from inonotus obliquus
11/27/2013CN102579488B Cell nutrient mineral bath material
11/27/2013CN102469821B Onion extract, and process for production thereof
11/27/2013CN102387800B Rosuvastatin and atorvastatin derivatives
11/27/2013CN102329325B Pyrrolopyrimidone dipeptidyl peptidase-IV (DPP-IV) inhibitors
11/27/2013CN102311447B Heterocyclo pyrimidone dipeptidyl peptidase-IV (DPP-IV) inhibitor
11/27/2013CN102228673B Capsules for treating diabetes and preparation method thereof
11/27/2013CN102197044B Peptide having anti-diabetic activity and use thereof
11/27/2013CN102018852B Ginseng and coptis capsule for quenching thirsty and reducing blood sugar and preparation process
11/26/2013US8592580 Substituted triazinone derivatives
11/26/2013US8592372 Pharmaceutical composition and method of use to improve organ function
11/26/2013US8592369 Lactoferrin and gut neuronal health in adults and/or elderly
11/26/2013CA2684999C Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith
11/26/2013CA2663584C Composition and method for treating iron deficiency anemia
11/26/2013CA2661892C Gel type enteral nutrient
11/26/2013CA2610361C Combination of 3-{(2s,4s)-4-[4-(3-methyl-1-phenyl-1h-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-ylcarbonyl}thiazolidine and a second active agent and use thereof for plasma glucose control
11/26/2013CA2600550C Composition and method for modulating hydrogen ion physiology
11/26/2013CA2549103C Use of a fatty acid composition comprising at least one of epa and dha or any combinations thereof
11/26/2013CA2429839C Compositions for preventing or ameliorating multiple risk factor syndromes
11/26/2013CA2378562C Method for producing oligopolysaccharides
11/21/2013WO2013173417A2 Glucokinase activator compositions for the treatment of diabetes
11/21/2013WO2013173198A1 Pyrimidinylpiperidinyloxypyridone analogues as gpr119 modulators
11/21/2013WO2013172728A1 Agent for correcting metabolic syndrome
11/21/2013WO2013172682A1 Use of flavone compound for prevention or treatment of obesity
11/21/2013WO2013172528A1 Novel use for asterubin
11/21/2013WO2013172421A1 Ampk protein activator screening method, and ampk protein activator
11/21/2013WO2013172346A1 Highly unsaturated fatty acid or highly unsaturated fatty acid ethyl ester with reduced environmental pollutants, and method for producing same
11/21/2013WO2013171756A1 Amorphous form of linagliptin and process for preparation thereof
11/21/2013WO2013171687A1 1-(p-tolyl)cyclopropyl substituted bridged spiro[2.4]heptane derivatives as alx receptor agonists
11/21/2013WO2013170769A1 Pharmaceutical composition for regulating blood lipids and uses thereof
11/21/2013WO2013170636A1 Protein and protein conjugate for diabetes treatment, and applications thereof
11/21/2013WO2013170385A1 Oligonucleotide chelate complex methods
11/21/2013WO2013149258A3 Compositions and methods for treating or preventing metabolic syndrome disorders
11/21/2013WO2013084210A9 Amorphous form of sitagliptin salts
11/21/2013WO2012169897A8 Weight reducing material
11/21/2013US20130310388 Modulators of TNF-Alpha Signaling
11/21/2013US20130310313 Polypeptides, nucleic acid molecule encoding polypeptides, and uses of polypeptides
11/21/2013US20130309325 Composition and method for promoting joint and bone health
11/21/2013US20130309236 Anti-interferon-alpha antibodies
11/21/2013US20130309232 Vascular endothelial growth factor 2
11/21/2013US20130309215 Pharmaceutical composition
11/20/2013EP2664338A1 Suppressor for increase in blood gip level, suppressor for increase in blood insulin level, postprandial blood triglyceride level reducing agent, and suppressor for increase in blood glucose level
11/20/2013EP2664333A1 Polymeric iron chelating agent
11/20/2013EP2664328A1 Omega3 fatty acid compound preparation
11/20/2013EP2663323A1 Methods targeting mir-128 for regulating cholesterol/lipid metabolism
11/20/2013EP2663186A1 Lipid-lowering antidiabetic agent
11/20/2013EP2663185A1 Anti-obesity potential of calebin a
11/20/2013EP2531501B1 Apoptosis signal-regulating kinase 1 inhibitors
11/20/2013EP2529742B1 Pharmaceutical composition comprising dapagliflozin and cyclodextrin
11/20/2013EP2490695B1 Method of preventing type 1 diabetes
11/20/2013EP2480532B1 Piperidine derivatives and their use to treat obesity, diabetes, dyslipidemia and atherosclerosis
11/20/2013EP2459207B1 Pharmaceutical composition for use in treating obesity, diabetes or to increase insulin sensitivity
11/20/2013EP2414348B1 Bicyclic piperidine and piperazine derivatives as gpcr modulators for the treatment of obesity, diabetes and other metabolic disorders
11/20/2013EP2389226B1 Bridged and fused heterocyclic antidiabetic compounds
11/20/2013EP2350022B1 New benzimidazole derivatives
11/20/2013EP2346834B1 3-amino-indazole or 3-amino-4,5,6,7-tetrahydro-indazole derivatives
1 ... 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 ... 1298